Trading Signals: EYES Stock Price Prediction and Forecast (Thu. Mar. 10, 2016 - Mon. Jun. 28, 2021)(Second Sight Medical Products Inc)
| EYES latest price $5.2100 (3.99%) ($4.7200 - $5.2300) on Fri. Feb. 7, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.31% (three month average) | RSI | 53 | Latest Price | $5.2100(3.99%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EYES declines -3.2% a day on average for past five trading days. | Weekly Trend | EYES advances 7% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EYES advance at 0% a week (0% probability) IGOV(20%) SHY(20%) VXX(19%) TLT(12%) BND(11%) | Factors Impacting EYES price | EYES will decline at least -2.655% in a week (0% probabilities). URA(-16%) TBT(-15%) QQQ(-14%) ONLN(-14%) EWI(-14%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.655% (StdDev 5.31%) | Hourly BBV | 0 () | Intraday Trend | 4.4% | | | |
|
5 Day Moving Average | $5.1(2.16%) | 10 Day Moving Average | $5.1(2.16%) | 20 Day Moving Average | $5(4.2%) | To recent high | -29.1% | To recent low | 4% | Market Cap | $1.664b | | | | Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, the Company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. The Company's headquarters are in Los Angeles, California. |